fda_483 · inspection_citation · high

Intas Pharmaceutical Limited -- FDA 483: 3 observations (2025-09-17)

Event date
2025-09-17 00:00:00Z
Observed
2026-07-12 22:31:37Z
Source ID
3005890633-2025-09-17-192689
Payload hash
44582f52d1769692b37a7cd1

Summary

Observation 1: There is a failure to thoroughly review any unexplained discrep ancy whether or n ot the batch has been ah eady distributed. Specifically, A. Shelf-life of the diug product <6>< 4 > Tab...

Informational only. Not legal, financial, or medical advice.